Our data support the hypothesis that in DCIS, c-Src may play a role in tumour proliferation, development of higher grade lesions and may facilitate progression to invasive recurrences and as such represent tractable drug targets in both DCIS and invasive breast carcinomas. The gene discussed is SRC; the disease is invasive breast carcinoma.